Aldeyra Therapeutics (ALDX) Earnings Date, Estimates & Call Transcripts $2.42 +0.10 (+4.31%) Closing price 04:00 PM EasternExtended Trading$2.46 +0.04 (+1.86%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Aldeyra Therapeutics Earnings Summary Upcoming Earnings DateMay. 1Before Market OpensEstimatedConsensus EPS (Mar. 6) $0.03 Actual EPS (Mar. 6) -$0.27 Missed By -$0.30 Aldeyra Therapeutics issued Q4 2024 earnings on March 6, 2025, reporting an EPS of -$0.27, which missed analysts' consensus estimates of $0.03 by $0.30. With a trailing EPS of -$0.94, Aldeyra Therapeutics' earnings are expected to grow next year, from ($0.92) to ($0.17) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Annual Report (10-K)ALDX Upcoming EarningsAldeyra Therapeutics' Q1 2025 earnings is scheduled for Thursday, May 1, 2025, with a conference call scheduled on Friday, May 2, 2025 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Aldeyra Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aldeyra Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataALDX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Aldeyra Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.27-$0.25-$0.26Q2 20252-$0.26-$0.23-$0.25Q3 20252-$0.20-$0.17-$0.19Q4 20252-$0.33-$0.14-$0.24FY 20258($1.06)($0.79)($0.93) Aldeyra Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/1/2025(Estimated)--------3/6/2025Q4 2024$0.03-$0.27 -$0.30-$0.27--11/7/2024--$0.25-$0.25--$0.25--5/2/2024Q1 2024-$0.08-$0.14 -$0.06-$0.14--3/7/2024Q4 2023-$0.21-$0.08+$0.13-$0.08--11/3/2023Q3 2023--$0.14 -$0.14-$0.14--8/3/2023Q2 2023-$0.31-$0.15+$0.16-$0.15--5/4/2023Q1 2023-$0.30-$0.27+$0.03-$0.27-- Aldeyra Therapeutics Earnings - Frequently Asked Questions When is Aldeyra Therapeutics's earnings date? Aldeyra Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 1st, 2025 based off last year's report dates. Learn more on ALDX's earnings history. Did Aldeyra Therapeutics beat their earnings estimates last quarter? In the previous quarter, Aldeyra Therapeutics (NASDAQ:ALDX) missed the analysts' consensus estimate of $0.03 by $0.30 with a reported earnings per share (EPS) of ($0.27). Learn more on analysts' earnings estimate vs. ALDX's actual earnings. How much profit does Aldeyra Therapeutics generate each year? Aldeyra Therapeutics (NASDAQ:ALDX) has a recorded net income of -$37.54 million. ALDX has generated -$0.94 earnings per share over the last four quarters. What is Aldeyra Therapeutics's EPS forecast for next year? Aldeyra Therapeutics's earnings are expected to grow from ($0.92) per share to ($0.17) per share in the next year. More Earnings Resources from MarketBeat Related Companies Savara Earnings uniQure Earnings Bicycle Therapeutics Earnings UroGen Pharma Earnings GH Research Earnings Kura Oncology Earnings CorMedix Earnings Sage Therapeutics Earnings Maravai LifeSciences Earnings Tyra Biosciences Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon's Earnings Could Fuel a Rapid Breakout Tesla Earnings Miss, But Musk Refocuses and Bulls ReactQualcomm’s Range Narrows Ahead of Earnings as Bulls Step InCan IBM’s Q1 Earnings Spark a Breakout for the Stock?Genuine Parts: Solid Earnings But Economic Uncertainties RemainBreaking Down Taiwan Semiconductor's Earnings and Future UpsideArcher Aviation Unveils NYC Network Ahead of Key Earnings Report This page (NASDAQ:ALDX) was last updated on 4/23/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aldeyra Therapeutics, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Aldeyra Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.